Persisting fatigue in Hodgkin lymphoma survivors

A systematic review

L.A. Daniëls, S. Oerlemans, A.D. Krol, L.V. van de Poll-Franse, C.L. Creutzberg

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long-term symptoms and is often reported to interfere with daily life. We conducted a systematic review to determine prevalence, severity and predisposing factors of fatigue in HL survivors. A literature search was conducted up to August 2012. Twenty-two articles comparing HL survivors with norm population data met all predefined selection criteria. Prevalence rates, levels of fatigue and clinical relevance of the results were determined. Prevalence of fatigue ranged from 11–76 % in HL survivors compared to 10 % in the general population. Mean fatigue scores were 5–13 % higher compared to the normative population; these findings were clinically relevant in 7 out of 11 studies. Increasing age was associated with higher levels of fatigue in HL survivors. Treatment modality and stage of initial disease were not associated with higher fatigue levels, while comorbidities or other treatment sequelae seemed to impact on the levels of fatigue. HL survivors are at serious risk for developing clinically relevant, long-term fatigue. The impact of patient and treatment characteristics on risk of fatigue is limited. Focus for future research should shift to the role of late-treatment sequelae and psychological distress symptoms.
Keywords: Hodgkin lymphoma, Fatigue, Vitality, Health-related quality of life
Original languageEnglish
Pages (from-to)1023-1032
JournalAnnals of Hematology
Volume92
Issue number8
DOIs
Publication statusPublished - 2013

Fingerprint

Hodgkin Disease
Survivors
Patient Selection
Comorbidity

Cite this

Daniëls, L.A. ; Oerlemans, S. ; Krol, A.D. ; van de Poll-Franse, L.V. ; Creutzberg, C.L. / Persisting fatigue in Hodgkin lymphoma survivors : A systematic review. In: Annals of Hematology. 2013 ; Vol. 92, No. 8. pp. 1023-1032.
@article{ae85271fef334d86935a6fd764ddae61,
title = "Persisting fatigue in Hodgkin lymphoma survivors: A systematic review",
abstract = "Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long-term symptoms and is often reported to interfere with daily life. We conducted a systematic review to determine prevalence, severity and predisposing factors of fatigue in HL survivors. A literature search was conducted up to August 2012. Twenty-two articles comparing HL survivors with norm population data met all predefined selection criteria. Prevalence rates, levels of fatigue and clinical relevance of the results were determined. Prevalence of fatigue ranged from 11–76 {\%} in HL survivors compared to 10 {\%} in the general population. Mean fatigue scores were 5–13 {\%} higher compared to the normative population; these findings were clinically relevant in 7 out of 11 studies. Increasing age was associated with higher levels of fatigue in HL survivors. Treatment modality and stage of initial disease were not associated with higher fatigue levels, while comorbidities or other treatment sequelae seemed to impact on the levels of fatigue. HL survivors are at serious risk for developing clinically relevant, long-term fatigue. The impact of patient and treatment characteristics on risk of fatigue is limited. Focus for future research should shift to the role of late-treatment sequelae and psychological distress symptoms.Keywords: Hodgkin lymphoma, Fatigue, Vitality, Health-related quality of life",
author = "L.A. Dani{\"e}ls and S. Oerlemans and A.D. Krol and {van de Poll-Franse}, L.V. and C.L. Creutzberg",
year = "2013",
doi = "10.1007/s00277-013-1793-2",
language = "English",
volume = "92",
pages = "1023--1032",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "8",

}

Persisting fatigue in Hodgkin lymphoma survivors : A systematic review. / Daniëls, L.A.; Oerlemans, S.; Krol, A.D.; van de Poll-Franse, L.V.; Creutzberg, C.L.

In: Annals of Hematology, Vol. 92, No. 8, 2013, p. 1023-1032.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Persisting fatigue in Hodgkin lymphoma survivors

T2 - A systematic review

AU - Daniëls, L.A.

AU - Oerlemans, S.

AU - Krol, A.D.

AU - van de Poll-Franse, L.V.

AU - Creutzberg, C.L.

PY - 2013

Y1 - 2013

N2 - Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long-term symptoms and is often reported to interfere with daily life. We conducted a systematic review to determine prevalence, severity and predisposing factors of fatigue in HL survivors. A literature search was conducted up to August 2012. Twenty-two articles comparing HL survivors with norm population data met all predefined selection criteria. Prevalence rates, levels of fatigue and clinical relevance of the results were determined. Prevalence of fatigue ranged from 11–76 % in HL survivors compared to 10 % in the general population. Mean fatigue scores were 5–13 % higher compared to the normative population; these findings were clinically relevant in 7 out of 11 studies. Increasing age was associated with higher levels of fatigue in HL survivors. Treatment modality and stage of initial disease were not associated with higher fatigue levels, while comorbidities or other treatment sequelae seemed to impact on the levels of fatigue. HL survivors are at serious risk for developing clinically relevant, long-term fatigue. The impact of patient and treatment characteristics on risk of fatigue is limited. Focus for future research should shift to the role of late-treatment sequelae and psychological distress symptoms.Keywords: Hodgkin lymphoma, Fatigue, Vitality, Health-related quality of life

AB - Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long-term symptoms and is often reported to interfere with daily life. We conducted a systematic review to determine prevalence, severity and predisposing factors of fatigue in HL survivors. A literature search was conducted up to August 2012. Twenty-two articles comparing HL survivors with norm population data met all predefined selection criteria. Prevalence rates, levels of fatigue and clinical relevance of the results were determined. Prevalence of fatigue ranged from 11–76 % in HL survivors compared to 10 % in the general population. Mean fatigue scores were 5–13 % higher compared to the normative population; these findings were clinically relevant in 7 out of 11 studies. Increasing age was associated with higher levels of fatigue in HL survivors. Treatment modality and stage of initial disease were not associated with higher fatigue levels, while comorbidities or other treatment sequelae seemed to impact on the levels of fatigue. HL survivors are at serious risk for developing clinically relevant, long-term fatigue. The impact of patient and treatment characteristics on risk of fatigue is limited. Focus for future research should shift to the role of late-treatment sequelae and psychological distress symptoms.Keywords: Hodgkin lymphoma, Fatigue, Vitality, Health-related quality of life

U2 - 10.1007/s00277-013-1793-2

DO - 10.1007/s00277-013-1793-2

M3 - Article

VL - 92

SP - 1023

EP - 1032

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 8

ER -